Decades of archaeological research and discovery around the world have concluded that the rise of modern civilization is strictly linked to when humans shifted from a hunter-gatherer/subsistence lifestyle to one that was civilized-urbanized, with people settled into permanent towns and cities (Cochran and Harpending, 2009; Scarre and Fagan, 2016) . Civilization depended on the development of agriculture, which occurred when certain key plants found to provide nutrition and protection were taken from nature and genetically modified to be of increasing use by humankind, a process termed as "domestication" (Leach, 2003; Zohary et al., 2012) .
Domestication is defined as a process by which wild plants are artificially evolved into crop plants by selection of traits that are advantageous or desirable to humans (Bennici, 2005; Acquaah, 2012) . Domestication involves genetic modification by selection and/or breeding, creating crop plants that are increasingly improved in quality and yield, becoming abundant and dependable. The initial stages of domestication were critical because humans acted as (1) dispersal agents (managing the reproduction of cultivated plants and controlling the mobility, range, and density of domestic livestock); (2) agents of selection (favoring the reproductive success of particular phenotypic variants); and (3) ecosystem modifiers, which, along with natural environmental changes, alter the developmental conditions and hence the characteristics of associated organisms (Larson et al., 2013) .
The newfound ability to grow food allowed populations to coalesce and become stable, unleashing an explosion of cultural and technical development that continues through to the present (Cochran and Harpending, 2009 ). Plant domestication is considered to be the very cornerstone of civilization (Gray and Trigiano, 2010) because, without it, civilization as we know it today could not have developed.
Dependable nutrition and protection allowed humankind to shift attention from the daily necessities of finding food and shelter to the development of modern behavior (Henshilwood and Marean, 2003) , the common features of which are complex thought and creativity (Goody, 1977; Powell et al., 2009 ) and the ability to transmit such to others. The shift to modern behavior occurred in different regions of the world at different times, with the Middle East generally considered to be the first to become civilized .
Archaeological studies show that the first crop plants began to be domesticated in the Middle East about 11,000 years BP (Lev-Yadun et al. 2000; Pollock and Bernbeck, 2009 ) and included many of the staples, such as wheat, millets, and peas. Rice from Asia and New World beans and potatoes were domesticated by 10,000 BP and maize by 9000 BP. All of the crops that have been long associated with supplying humankind with nutrition and protection were genetically modifieddomesticated -throughout the ages (Doebley et al., 2006) . Indeed, all the foods found in the produce aisle of any grocery store were genetically modified from the beginning of their use. There are few, if any, exceptions.
Cannabis is among these most ancient plants to be genetically modified and domesticated, in this instance, into two distinct forms: hemp and drug varieties. Based upon fiber evidence, the earliest records for humankind's domestication of cannabis date from 8500 BP in China (Fleming and Clarke, 1998) . Due to its ready availability, strength, and versatility, cannabis became domesticated as a fiber crop (hemp) and is ubiquitously used for a wide array of products, ranging from clothing and rope to seed oil. Drug forms of cannabis were domesticated by 3000 BP (Schultes, 1967) . It must be concluded that cannabis has been an integral part of the human experience since the dawn of civilization and continues into the present.
For simplicity and because of confusion in the taxonomy of the genus Cannabis, this special issue will consider drug and hemp varieties to be a single species, Cannabis sativa L. with three subspecies -indica, sativa and ruderalis, although other species are mentioned in some chapters. This emphasizes the need to further study relatedness among members of the genus Cannabis. Efforts outlined in Lynch et al. and Vergara et al., with planned future investigations to understand the genome(s) of cannabis will certainly elucidate these relationships.
The euphoric and other effects of drug varieties were determined to be due to the recognition of their active ingredients by receptors in animal brains and immune systems, including those of humans (Chap. 6; Devane et al., 1988; Mackie, 2006) . "Cannabinoid receptors" are distinguished by their affinity to chemicals like those produced by cannabis. They currently are the subject of intense medical research. Considering the process of plant domestication, it is clear that drug characteristics were intentionally taken from the wild and genetically modified over time to increase their effects on our endogenous receptors. The development of drug forms of cannabis, driven by their effects on human cannabinoid receptors, represents a vivid example of directed artificial evolution via intentional selection, the basis of plant domestication.
In recent times, the United States had a large hemp fiber industry, as evidenced by the remnant feral cannabis plants still growing across the midwest. However, hemp production in the United States decreased and essentially stopped when cannabis became criminalized in the 1960s due to safety concerns of the drug varieties. It did not matter that hemp varieties contained very low concentrations of psychoactive compounds. All cannabis varieties, including those used for hemp, were made illegal to grow or possess (Duvall, 2014) .
Indeed, most research on cannabis ceased in the United States and became greatly reduced worldwide. Cannabis, one of our most ancient crops, long-valued for its multiple uses by our progenitors, became largely ignored during the last 50C years. Compared to other crop plants, modern scientific research and technology has not been brought to bear on cannabis so that much information remains to be discovered. A major gap in our contemporary knowledge of the cannabis crop remains to be filled.
In this special issue of Critical Reviews in Plant Sciences, we have asked noted experts to explore the many aspects and attributes of cannabis. There is now much discussion on reviving cannabis cultivation for fiber production in the United States and, indeed, some states now sanction the growing of hemp as do many countries worldwide. There is also increased interest in cannabis for medicinal and recreational uses, especially in the United States. With the recent US general election, a total of 29 states now have enacted legislation to permit cannabis use to treat specific ailments, and several now permit regulated commerce for private recreational use (Anon., 2016). Most recently (9-12-16), the U.S. Department of Human Health and Services along with the Drug Enforcement Administration, while declining to reschedule its safety as a drug, proposed to significantly increase the availability of cannabis for research by increasing the number of authorized manufacturers (DEA, 2016; Federal Register, 2016) . This act alone signals a potential sea change in the study and use of cannabis. It is likely that federally funded research on the crop will increase significantly in the near future. It is with this as a backdrop that we present the Special Issue on Cannabis in a most timely manner.
We open the discussion of cannabis with an article developed by Clarke and Merlin concerning the history of cannabis domestication, breeding efforts, and future studies. They explore the spread of cannabis from Eurasia throughout the world. These world authorities on the crop describe breeding efforts to develop cultivars with better fiber content and active drug characteristics. They explain that the drug varieties are now completely domesticated and dependent on humans for their continued survival.
The second article, by Rahn, Pearson, Trigiano, and Gray, discusses the derivation of modern cannabis drug varieties and aims to elucidate their origins. The authors have developed an extensive list of varieties in the trade and discuss the difficulties encountered in identifying their sources. The authors make a compelling argument concerning the overwhelming lack of current scientific data that stymies the determination of varietal identities.
The following article, "Genomic and Chemical Diversity in Cannabis," by Lynch et al., describes phytocannabinoids, which are a type of terpene. Cannabinoids are terpenophenolic compounds-part terpenoid and part phenol ring that interact with the endocannabinoid receptors found in animals. In this article, the authors explore the nuclear genome of a great many varieties of cannabis and conclude that there are three primary diversity groups. The elucidation of diversity of population genetics will aid in the understanding of the species for future agricultural as well as medicinal uses.
The fourth manuscript, by Vergara et al., is closely related to the preceding article. In this review, the authors evaluate modern tools for exploring the genome of Cannabis sativa. The authors draw on six whole genome assemblies, two transcriptomes, and a number of other genomic resources to derive conclusions and to point out future techniques that can be applied to genomics of the species as well as how our knowledge of the genome can be improved. Additional information provided by these studies will be essential to understand the evolutionary history, selection, and ecology of this important and versatile species.
We are now witnessing a great resurgence in possible applications of cannabis active moieties in medicine. In Grotenhermen & M€ uller-Vahl, the fifth article of this issue, the clinical trials of different cannabinoids, but primarily cannabidiols, are extensively chronicled for the treatment of various human diseases and conditions including nausea and vomiting side effects of chemotherapy in cancer patients, chronic pain, the treatment of uncontrolled motor and vocal manifestations of Tourette's syndrome, and even the spasticity found in victims of multiple sclerosis. Some of these trials have led to the approval of cannabis drugs for treatments in some jurisdictions in the world.
The production of cannabis for fiber (hemp) is likewise reviving into a viable industry involving many of the U.S. states, which have recently reduced or abolished many restrictions on growing the crop. "Industrial Hemp," by Fike, examines commercial exploitation of cannabis. Beyond the traditional uses of hemp for rope, canvas, and textiles, the crop has use as seed grains, food additives, and oils in a range of products including cosmetics, soaps, and medicines. Additional research is needed to optimize growing conditions and harvesting techniques as well as solving problems with disease and pests. Market development, especially in the United States, is essential for the success of the crop.
Finally, "Current and Future Needs and Applications for Cannabis" by Gray et al., finalizes the special issue. Our experts explore the future development and uses for cannabis based on each one's area of expertise. The chapter is wide ranging, based on current knowledge and understanding. However, no one really knows what the future will hold for humankind's ongoing use of this neglected crop.
The special issue on cannabis was conceived to present the most up-to-date information on genetics and diversity of the species, to consolidate current information on genomics, to clarify the relationships among the myriad of cultivars and strains, of which some are synonymous, to narrate the extensive clinical trials of cannabidiols as medicinal compounds to treat various human maladies, and to summarize and explore the resurgence of commercial hemp production. There is still much to learn about this fascinating and extremely versatile plant species. It is our hope and expectation that the manuscripts contained herein will stimulate additional ideas, conversations, and collaborations as well as provide a basis for future research involving cannabis.
